TSX Delisting Review - Ambrilia Biopharma Inc. (AMB)

    TORONTO, Aug. 5 /CNW/ - DELISTING REVIEW - Ambrilia Biopharma Inc. (the
"Company") - Further to TSX Bulletin 2009-0987 dated July 31, 2009, TSX's
review of the common shares of the Company (Symbol: AMB) has been stayed until
August 30, 2009, or such later date as the court may order, pursuant to the
Initial Order issued on January 21, 2008 by the Quebec Superior Court of
Justice under the Companies' Creditors Arrangement Act, R.S.C. 1985, c. C-36,
As Amended. The common shares will resume trading immediately.

    About TMX Group

    TMX Group's key subsidiaries operate cash and derivative markets for
multiple asset classes including equities, fixed income and energy. Toronto
Stock Exchange, TSX Venture Exchange, Montreal Exchange, Natural Gas Exchange,
Boston Options Exchange (BOX), Shorcan, Equicom and other TMX Group companies
provide trading markets, clearing facilities, data products and other services
to the global financial community. TMX Group is headquartered in Toronto with
offices in Montreal, Calgary and Vancouver. For more information about TMX
Group, visit our website at www.tmx.com.

For further information:

For further information: Corporate Communications, TMX Group Inc., Toll
Free 1-888-873-8392, info@tsx.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890